Related Experiment Video
Updated: Apr 17, 2026

Treatment Protocol for Rotator Cuff Calcific Tendinitis Using a Single-Crystal Piezoelectric Focused Shock Wave Source
Published on: December 23, 2022
Hyperbaric oxygen in the treatment of calciphylaxis: A case series and literature review
Jennifer An1, Bridget Devaney2, Khai Yang Ooi1
1Department Renal Medicine, Alfred Hospital, Melbourne, Victoria, Australia.
Insights
Hyperbaric oxygen therapy (HBOT) shows promise for treating calcific uraemic arteriolopathy (CUA), also known as calciphylaxis. Over half of patients receiving HBOT experienced wound healing and improved survival, with diabetes being a key predictive factor.
Area of Science:
- Nephrology
- Dermatology
- Vascular Surgery
Background:
- Calcific uraemic arteriolopathy (CUA), or calciphylaxis, is a severe condition often seen in end-stage renal disease patients.
- CUA is characterized by significant morbidity and mortality, posing a challenge in treatment.
- Identifying effective therapies for CUA is crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of hyperbaric oxygen therapy (HBOT) in healing CUA lesions.
- To identify patient-specific factors that predict wound healing and survival in CUA patients treated with HBOT.
Main Methods:
- Retrospective review of CUA patients treated with HBOT at the institution.
- Documentation of clinical and biochemical parameters, lesion characteristics, wound outcomes, and survival.
- Analysis of patient data to determine factors associated with treatment success.
Main Results:
- 46 patients with renal failure-associated CUA were identified; 34 completed HBOT.
- 58% of patients receiving HBOT showed wound improvement, with over half achieving complete healing.
- Patients benefiting from HBOT survived over 3 years on average; diabetes was linked to better outcomes.
Conclusions:
- HBOT appears to be a beneficial treatment for CUA, improving wound healing and survival rates.
- More than half of patients undergoing HBOT experienced positive outcomes, including extended survival.
- Diabetes emerged as a significant predictor of improved wound healing and survival in CUA patients treated with HBOT.
Aims:
Calcific uraemic arteriolopathy (CUA) or calciphylaxis is most commonly seen in end-stage renal disease and is associated with significant morbidity and mortality. The aim of this study was to determine whether hyperbaric oxygen therapy (HBOT) is effective in healing calciphylaxis lesions and to determine if there are any patient factors that can predict wound healing and patient survival.
Methods:
We identified by retrospective review all cases of CUA referred to our institution for treatment with HBOT. We documented the clinical and biochemical parameters of this patient population, the size and distribution of the lesions as well as wound outcomes and patient survival following treatment.
Results:
A total 46 patients were identified with CUA associated with renal failure. Of the 46 patients, only 34 received a full course of HBOT. The balance was deemed unsuitable for treatment or was unable to tolerate treatment and was palliated. Of the 34 patients that received a full course of HBOT, 58% showed improvement in their wound scores, with more than half of these patients having complete healing of their wounds. The balance did not benefit from the therapy and had a very poor prognosis. Those that benefited from HBOT survived on average for more than 3 years. The only factor significantly associated with improved wound healing and survival was diabetes.
Conclusion:
This retrospective analysis suggests a role for HBOT in the treatment of CUA with more than half of the treated patients benefiting and surviving for an average of more than 3 years.
More Related Videos
10:50Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging
Published on: June 29, 2013
15:39Characterization of Calcification Events Using Live Optical and Electron Microscopy Techniques in a Marine Tubeworm
Published on: February 28, 2017
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Peripheral Artery Disease III: Interprofessional Care
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pneumothorax-II
Clinical Manifestations:
Venous Thrombosis III: Interprofessional Care